Tony Cannon Joins Life Science Connect as Chief Financial Officer

May 28, 2026 | News

Pittsburgh, PA – May 28, 2026

Life Science Connect (or “LSC”) is pleased to announce the appointment of Tony Cannon as its Chief Financial Officer. LSC welcomes Mr. Cannon to the team at a pivotal moment as the Company continues to strengthen its financial infrastructure and capabilities to support its continued growth. LSC is a portfolio company of Latticework Capital Management and Edgehill Management.

LSC, headquartered in Pittsburgh, Pennsylvania, operates a network of trusted editorial communities and events serving professionals across the life sciences industry. Through independent journalism and expert-driven content, LSC builds engaged audiences that inform critical decisions across research, development, manufacturing, and commercialization. LSC’s model is built on the strength of its editorial communities, with commercial programs designed to help life science organizations engage these audiences in meaningful, data-driven ways.

Mr. Cannon brings more than 28 years of financial leadership experience in marketing communications and healthcare services to Life Science Connect. Throughout his career, Mr. Cannon has developed deep expertise in M&A, financial stewardship, and strategic growth, serving as CFO for multiple healthcare-focused marketing companies including Pivot Health+Wellness (15 years), PACE, and Interlink Healthcare Communications. He most recently served as CFO at Mod Op, a marketing communications agency, where he guided the company’s financial strategy during a period of significant growth. Mr. Cannon’s extensive experience in healthcare finance, combined with his proven track record in M&A transactions and operational leadership at advertising and marketing firms, positions him ideally to support Life Science Connect’s continued expansion as the company serves its clients and readers.

“Joining Life Science Connect at this stage of its growth journey is an extraordinary opportunity,” said Mr. Cannon. “What drew me here is the strength of a business built on four decades of trust — with readers, clients, and partners alike. My focus will be on building the financial infrastructure and discipline that empowers every part of this organization to scale with confidence. LSC has all the right ingredients: a differentiated market position, a deeply engaged audience, and a leadership team committed to excellence. I look forward to channeling that foundation into sustainable, long-term value creation for our clients, our people, and the life science community we serve.”

“We’re thrilled to welcome Mr. Cannon to the team,” said Jon Howland, CEO. “It’s rare to find a partner who checks every box on both your must-have and wish lists, but that is what we have with Tony. His strong financial, international, and M&A experience aligns perfectly with what we need as a fast-growing B2B media and events company. His background in marketing, artificial

intelligence, and data science will bring valuable perspective as we continue to scale the business.”

LSC continues to evaluate acquisition and growth opportunities that expand its capabilities, audiences, and reach across the life sciences industry. Organizations interested in exploring a potential acquisition or partnership may contact Jon Howland (jon.howland@lifescienceconnect.com) to connect further regarding a potential partnership.

About Life Science Connect

Life Science Connect operates digital communities, data platforms, and live events serving professionals across the life sciences. The company brings together industry stakeholders to support knowledge sharing, collaboration, and commercial engagement across research, development, manufacturing, and commercialization. Its mission is to accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices.

Connect. Collaborate. Contribute. Learn more at www.lifescienceconnect.com.

Contact:
Jeremy Milner
Gregory
jmilner@gregoryagency.com
(401) 862-9422

More News

Why PharmaSource and CDMO Live Are Joining LSC

Why PharmaSource and CDMO Live Are Joining LSC

Life Science Connect CEO Jon Howland recently joined PharmaSource Co-Founder Luke Bilton for a conversation about LSC’s acquisition of PharmaSource, CDMO Live, and External Manufacturing Leaders, and what this next chapter means for the biopharma outsourcing...

Kyle Turner Joins Life Science Connect as Chief Growth Officer

Pittsburgh, PA – January 7, 2026 Life Science Connect (or “LSC”) is pleased to announce the appointment of Kyle Turner as its Chief Growth Officer. Mr. Turner’s addition to the team comes at a pivotal moment as the Company looks to amplify its growth capabilities to...

Free Download

Complete the form to download our media kit.

Explore Life Science Connect’s audience data, communities, and solutions all in one place.

Select at least one.

Fields marked with * are required. Your information is secure. We will never sell your data or share it with third parties outside of Life Science Connect. By submitting this form, you acknowledge that your data will be processed in accordance with our Privacy Policy.

Your information is kept private and never sold.